Deutsch English Français

Contact

EP1718290

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1718290

EP1718290 - COMPOSITION, COMPRISING L-SERINE, L-ISOLEUCINE, FOLIC ACID AND TRACE ELEMENTS, FOR TREATING PSORIASIS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 11.03.2011 Database last updated on 02.08.2024
Most recent event Tooltip	13.09.2013	Lapse of the patent in a contracting state New state(s): BG	published on 16.10.2013 [2013/42]
Applicant(s)	For all designated states Oy Neurofood Ab c/o Oy Julius Tallberg Ab Suomalaistentie 7 02270 Espoo / FI
	[2010/09]
Former [2006/45]	For all designated states Helsingfors Institution för Bioimmunterapi Ab Oy Julius Tallberg, Karaäkesrvägen 11 02610 Esbo / FI
Inventor(s)	01 / TALLBERG, Thomas Enasvägen 16 A 2 FI-00200 Helsingfors / FI
	[2006/45]
Representative(s)	Boije-Backman, Solveig Magdalena, et al Kolster OY AB Iso Roobertinkatu 23 P.O. Box 148 00121 Helsinki / FI
	[N/P]
Former [2006/45]	Boije-Backman, Solveig Magdalena, et al Kolster Oy Ab, Iso Roobertinkatu 23, P.O. Box 148 00121 Helsinki / FI
Application number, filing date	05708155.6	04.02.2005
	[2006/45]
	WO2005FI00075
Priority number, date	FI20040000180	06.02.2004 Original published format: FI 20040180
	[2006/45]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2005074910
	Date:	18.08.2005
	Language:	EN
	[2005/33]
	Type:	A1 Application with search report
	No.:	EP1718290
	Date:	08.11.2006
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 18.08.2005 takes the place of the publication of the European patent application.
	[2006/45]
	Type:	B1 Patent specification
	No.:	EP1718290
	Date:	05.05.2010
	Language:	EN
	[2010/18]
Search report(s)	International search report - published on:	SE	18.08.2005
Classification	IPC:	A61K31/198, A61K33/00, A61K31/519, A61P17/06	[2006/45]
	CPC:	A61K31/519 (EP,US); A61K31/198 (EP,US); A61K33/04 (EP,US); A61K33/24 (EP,US); A61P17/06 (EP)
	C-Set:	A61K31/198, A61K2300/00 (EP,US); A61K31/519, A61K2300/00 (US,EP); A61K33/04, A61K2300/00 (US,EP); A61K33/24, A61K2300/00 (US,EP)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/45]
Extension states	AL	Not yet paid
	BA	Not yet paid
	HR	16.08.2006
	LV	16.08.2006
	MK	Not yet paid
	YU	Not yet paid
Title	German:	ZUSAMMENSETZUNG MIT L-SERIN, L-ISOLEUCIN, FOLSÄURE UND SPURENELEMENTEN ZUR BEHANDLUNG VON PSORIASIS	[2006/45]
	English:	COMPOSITION, COMPRISING L-SERINE, L-ISOLEUCINE, FOLIC ACID AND TRACE ELEMENTS, FOR TREATING PSORIASIS	[2006/45]
	French:	COMPOSITION A BASE DE L-SERINE, DE L-ISOLEUCINE, D'ACIDE FOLIQUE ET D'OLIGO-ELEMENTS, UTILISEE DANS LE TRAITEMENT DU PSORIASIS	[2006/45]
Entry into regional phase	16.08.2006	National basic fee paid
	16.08.2006	Designation fee(s) paid
	16.08.2006	Examination fee paid
Examination procedure	11.05.2005	Request for preliminary examination filed International Preliminary Examining Authority: EP
	16.08.2006	Examination requested [2006/45]
	11.09.2007	Despatch of a communication from the examining division (Time limit: M04)
	03.12.2007	Reply to a communication from the examining division
	22.12.2008	Despatch of a communication from the examining division (Time limit: M04)
	22.04.2009	Reply to a communication from the examining division
	18.01.2010	Communication of intention to grant the patent
	23.03.2010	Fee for grant paid
	23.03.2010	Fee for publishing/printing paid
Opposition(s)	08.02.2011	No opposition filed within time limit [2011/15]
Fees paid	Renewal fee
	16.08.2006	Renewal fee patent year 03
	20.02.2008	Renewal fee patent year 04
	20.02.2009	Renewal fee patent year 05
	23.02.2010	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CY	05.05.2010
	EE	05.05.2010
	FI	05.05.2010
	LT	05.05.2010
	RO	05.05.2010
	SI	05.05.2010
	SK	05.05.2010
	BG	05.08.2010
	GR	06.08.2010
	IS	05.09.2010
	LU	04.02.2011
	[2013/42]
Former [2013/25]	CY	05.05.2010
	EE	05.05.2010
	FI	05.05.2010
	LT	05.05.2010
	RO	05.05.2010
	SI	05.05.2010
	SK	05.05.2010
	GR	06.08.2010
	IS	05.09.2010
	LU	04.02.2011
Former [2011/11]	CY	05.05.2010
	EE	05.05.2010
	FI	05.05.2010
	LT	05.05.2010
	RO	05.05.2010
	SI	05.05.2010
	SK	05.05.2010
	GR	06.08.2010
	IS	05.09.2010
Former [2011/03]	CY	05.05.2010
	FI	05.05.2010
	LT	05.05.2010
	SI	05.05.2010
	GR	06.08.2010
	IS	05.09.2010
Former [2011/01]	FI	05.05.2010
	LT	05.05.2010
	SI	05.05.2010
	GR	06.08.2010
	IS	05.09.2010
Former [2010/52]	FI	05.05.2010
	LT	05.05.2010
	SI	05.05.2010
	IS	05.09.2010
Cited in	International search	[A]WO8901930 (DEXTER BIOTECHNICS [US]);
		[A]US5006337 (MOTITSCHKE LOTHAR [DE], et al);
		[A]GB2370504 (BUCHANAN-BAILLIE-HAMILTON PAUL [GB]);
		[AP]US2004086583 (JENSEN CLAUDE JARAKAE [US], et al);
		[A] - TALLBERG T. ET AL, "Development of a Combined Biological and Immunological Cancer Therapy Modality", JOURNAL OF AUSTRALIAN COLLEGA OF NUTRITIONAL AND EVIRONMENTAL MEDICINE, (20030401), vol. 22, no. 1, pages 3 - 21, XP002987380
		[A] - TALLBERG T. ET AL, "Studies on Mitochondrial Regulation of the Genome", DEUTSCHE ZEITSCHRIFT FUER ONKOLOGIE, (2002), vol. 34, pages 128 - 139, XP002987381 DOI: http://dx.doi.org/10.1055/s-2002-36554

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p